PAMP
ATXS

Polar Asset Management Partners’s Astria Therapeutics ATXS Stock Holding History

Polar Asset Management Partners’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-56,300
Closed -$512K – 726
2024
Q2 		$512K Buy
56,300
+8,000
+17% +$78.1K 0.01% 427
2024
Q1 		$680K Buy
+48,300
New +$602K 0.01% 456
2023
Q4 		– Sell
-154,200
Closed -$1.15M – 799
2023
Q3 		$1.15M Hold
154,200
– – 0.03% 439
2023
Q2 		$1.28M Hold
154,200
– – 0.02% 491
2023
Q1 		$2.05M Buy
154,200
+75,300
+95% +$1.02M 0.03% 510
2022
Q4 		$1.17M Buy
+78,900
New +$814K 0.01% 676

Other funds holding ATXS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Polar Asset Management Partners's ATXS Position: Q3 2024 in Review

Polar Asset Management Partners sold out of Astria Therapeutics (ATXS) in Q3 2024, closing a stake of 56,300 shares — an estimated $512K sold.

Polar Asset Management Partners first reported a position in ATXS in Q4 2022 and held it in 6 quarters. The position peaked at $2.05M in Q1 2023. 103 funds tracked by Wall St. Rank hold ATXS as of Q3 2024.

  • Polar Asset Management Partners reported no remaining Astria Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 56,300 Astria Therapeutics shares in Q3 2024, an estimated $512K.
  • Polar Asset Management Partners first reported a position in Astria Therapeutics in Q4 2022 and held it in 6 quarters.
  • Polar Asset Management Partners's Astria Therapeutics position peaked at $2.05M in Q1 2023.
  • 103 funds tracked by Wall St. Rank held Astria Therapeutics as of Q3 2024.

Based on Polar Asset Management Partners's 13F filing for Q3 2024, filed 14 Nov 2024.